Am I Eligible for Foundayo? Who Qualifies for the Oral GLP-1 Pill
Reading Time: 5 minutesA physician explains Foundayo eligibility: BMI criteria, medical conditions, contraindications, and when orforglipron may not be right for you.
How orforglipron, semaglutide, and tirzepatide are reshaping primary-care prescribing — read in plain English by a working physician.
52 stories · Updated May 21, 2026
Reading Time: 5 minutesA physician explains Foundayo eligibility: BMI criteria, medical conditions, contraindications, and when orforglipron may not be right for you.
Reading Time: 5 minutesA physician compares Foundayo (orforglipron), Wegovy (semaglutide), and Zepbound (tirzepatide) on efficacy, side effects, cost, and convenience.
Reading Time: 5 minutesA physician breaks down the ATTAIN-1 trial: 11.2% weight loss on orforglipron 36mg, responder rates, and what the data means for patients considering Foundayo.
Reading Time: 5 minutesThe FDA approved Foundayo (orforglipron) in April 2026. A physician explains what the first oral non-peptide GLP-1 drug means for weight management.